Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7567 USD | -0.32% | -4.22% | -32.44% |
May. 20 | Bolt Biotherapeutics, Inc. Announces Management Changes | CI |
May. 20 | Bolt Biotherapeutics, Inc. Announces Chief Executive Officer Changes | CI |
Financials (USD)
Sales 2024 * | 8.5M | Sales 2025 * | 19.94M | Capitalization | 28.85M |
---|---|---|---|---|---|
Net income 2024 * | -45M | Net income 2025 * | -47M | EV / Sales 2024 * | -19.6 x |
Net cash position 2024 * | 196M | Net cash position 2025 * | 244M | EV / Sales 2025 * | -10.8 x |
P/E ratio 2024 * |
-0.61
x | P/E ratio 2025 * |
-0.8
x | Employees | 100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.53% |
1 day | -0.32% | ||
1 week | -4.22% | ||
1 month | -32.44% | ||
3 months | -37.46% | ||
6 months | -14.98% | ||
Current year | -32.44% |
Managers | Title | Age | Since |
---|---|---|---|
William Quinn
CEO | Chief Executive Officer | 53 | 20-04-30 |
John Tomaro
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Priti Hegde
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Miller
BRD | Director/Board Member | 73 | 17-06-30 |
Mahendra Shah
BRD | Director/Board Member | 79 | 16-08-31 |
James Healy
BRD | Director/Board Member | 59 | 20-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.7567 | -0.32% | 54,498 |
24-05-30 | 0.7591 | -0.12% | 73,596 |
24-05-29 | 0.76 | -0.11% | 101,480 |
24-05-28 | 0.7608 | -3.70% | 193,194 |
24-05-24 | 0.79 | +2.00% | 562,369 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.44% | 28.85M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- BOLT Stock